Skip to content

Clinical Application and Efficacy Analysis of Laparoscopic Hepatic Sectional Choledocholithotomy Without T-Tube Drainage for Treating Intra- and Extrahepatic Bile Duct Stones

Clinical Application and Efficacy Analysis of Laparoscopic Hepatic Sectional Choledocholithotomy Without T-Tube Drainage for Treating Intra- and Extrahepatic Bile Duct Stones

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126209
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of intrahepatic and extrahepatic bile duct stones

Interventions

Observation group: Laparoscopic hepatectomy, choledocholithotomy via hepatic parenchymal dissection with intraoperative choledochoscopy
:None
Control group: laparoscopic hepatectomy, common bile duct incision, choledochoscopy for stone extraction, and T-tube drainage:None

Sponsors

Ankang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Intrahepatic bile duct stones combined with extrahepatic bile duct stones: Abdominal ultrasound, CT or MRCP examination suggests intrahepatic bile duct stones combined with extrahepatic bile duct stones; 2. There are indications for surgery, but no contraindications. Laparoscopic liver resection combined with intraoperative cholangioscopy exploration and stone removal surgery is performed for surgical treatment; 3. No previous history of endoscopic retrograde cholangiopancreatography (ERCP) examination or treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with concurrent malignant tumors of the liver or biliary tract or other parts of the body; 2. Patients with concurrent acute cholangitis or acute pancreatitis; 3. Patients with severe stenosis of extrahepatic bile ducts; 4. Patients with severe cardiovascular, pulmonary, and cerebrovascular diseases cannot tolerate surgery; 5. Individuals with severe coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
Surgical indicators: blood loss and operative time in both groups;

Secondary

MeasureTime frame
Postoperative complication indicators: number of cases of bile leakage, bile duct bleeding, and incision infection;Postoperative recovery indicators: time to recover intestinal function;Long term efficacy indicators: number of recurrent cases of stones;

Countries

China

Contacts

Public ContactXia Jie

Ankang Central Hospital

865436990@qq.com+86 915 328 4124

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026